|
  
- 积分
- 68
- 威望
- 68
- 包包
- 742
|
Panel Discussion: Taking Research from the Labs to the Clinic: Legal, Translational and Regulatory Challenges for Stem Cell Companies $ l2 i$ [$ ~% I) ]* v) V: P" P. _
Experts will address the intellectual property, translational and regulatory challenges impacting the development of stem cell products and propose solutions to advance commercial applications.
9 k" {7 R$ v$ D8 Y- A" W5 E' G9 t% G" q3 W1 t
S. Peter Ludwig, Darby & Darby
2 m1 Y/ k3 c. r; U+ XMark Ellinger, Fish & Richardson 3 V3 c* f6 A2 g% O1 g% K
Annemarie Moseley, CEO, Aggregate Therapeutics ( g$ O& J2 h* q& a1 Y* m) O
Pedro Huertas, Chief Development Officer, Advanced Cell Technology
6 S# u r2 I$ |9 X; i8 s
: V+ e, m5 X" wModerator: Frances Toneguzzo, PhD, Director, Corporate Sponsored Research & Licensing, Massachusetts General Hospital o; i, h+ C; s( k7 a
|
|
发表于 2009-5-6 09:30
发表于 2025-5-26 05:23
